Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Oximes developed as antidotes for organophosphates present a scaffold for new research(es) candidates (CROSBI ID 727779)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | domaća recenzija

Zandona, Antonio ; Maraković, Nikola ; Katalinić Maja Oximes developed as antidotes for organophosphates present a scaffold for new research(es) candidates // Book of abstracts of 6th Mini Symposium of Section of Medicinal and Pharmaceutical Chemistry. Zagreb, 2022. str. 2-2

Podaci o odgovornosti

Zandona, Antonio ; Maraković, Nikola ; Katalinić Maja

engleski

Oximes developed as antidotes for organophosphates present a scaffold for new research(es) candidates

Scaffolds for development of the antidotes for organophosphates, have one or more nucleophilic oxime group(s) along with the presence of aromatic rings, alcohol groups, nitrogen and chlorine atoms. Their main purpose is to reactivate activity of acetylcholinesterase in synapses upon covalent inhibition by highly toxic organophosphorus compounds (nerve agents, pesticides). However, a lot of designed and synthetized oximes do not reach the expected efficiency level in in vitro experiments as antidotes, and they usually get discarded from further evaluations. To prevent such compounds from being forgotten and unused for other research objective, we evaluated them thorough the cell- based assays and determined their new potential targets. We focused our research on a set of quinuclidinium oximes (Qox). Our results indicate that compounds having a longer alkyl chain in the structure disrupt cell and mitochondria membrane fluidity by mimicking fatty acids. Causing changes in membranes, they activate caspase 8 mediated by the death receptor. However, due to the simultaneous influence on the integrity of the membrane, we did not observe the activation of apoptosis but only immediate necrosis. Additionally, computational pharmacophore modelling revealed pharmacological potential of Qox as inhibitors for the enzyme ALDH1. Moreover, changes in ALDH1 lead to cancer progression and therapy resistance, which makes our findings interesting and worth further investigation. This work was supported by the Croatian Science Foundation (HrZZ-UIP-2017-05-7260).

quinuclidinium ; oximes ; repurposing ; cytotoxicity ; apoptotis

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

2-2.

2022.

objavljeno

Podaci o matičnoj publikaciji

Book of abstracts of 6th Mini Symposium of Section of Medicinal and Pharmaceutical Chemistry

Zagreb:

Podaci o skupu

6th Mini Symposium of Section of Medicinal and Pharmaceutical Chemistry

predavanje

22.11.2022-22.11.2022

Zagreb, Hrvatska

Povezanost rada

Biologija, Kemija